Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00408629 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

NCT02065557 ·Status: COMPLETED ·Phase: PHASE3

Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

NCT02092389 ·Status: TERMINATED

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02163759 ·Status: COMPLETED ·Phase: PHASE3

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

NCT00348283 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03653026 ·Status: COMPLETED ·Phase: PHASE3

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00409617 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

NCT01494857 ·Status: UNKNOWN ·Phase: PHASE3

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

NCT00427921 ·Status: COMPLETED ·Phase: PHASE3

Prognosis in UC After First Biological

NCT05530122 ·Status: COMPLETED

Adalimumab-psoriasis and Small Bowel Lesions

NCT01556672 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

NCT02065570 ·Status: COMPLETED ·Phase: PHASE3

Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

NCT05372939 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02171429 ·Status: COMPLETED ·Phase: PHASE3

A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

NCT04183608 ·Status: RECRUITING ·Phase: PHASE4

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

NCT01716039 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

NCT01671956 ·Status: TERMINATED ·Phase: PHASE2

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00077779 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT02819635 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02499783 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

NCT02632175 ·Status: COMPLETED ·Phase: PHASE3

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis

NCT03142113 ·Status: COMPLETED

Clinical Outcome of Treatment of Ulcerative Colitis in Adult

NCT06143163 ·Status: NOT_YET_RECRUITING

Adalimumab in the Treatment of Chronic Pouchitis

NCT01670240 ·Status: COMPLETED ·Phase: PHASE3